Suppr超能文献

鉴定作为肠道胆固醇转运蛋白成分的胆固醇吸收抑制剂结合蛋白。

Identification of binding proteins for cholesterol absorption inhibitors as components of the intestinal cholesterol transporter.

作者信息

Kramer W, Glombik H, Petry S, Heuer H, Schäfer H, Wendler W, Corsiero D, Girbig F, Weyland C

机构信息

Aventis Pharma Deutschland GmbH, Disease Group Metabolic Diseases, D-65926, Frankfurt am Main, Germany.

出版信息

FEBS Lett. 2000 Dec 29;487(2):293-7. doi: 10.1016/s0014-5793(00)02372-3.

Abstract

To identify protein components of the intestinal cholesterol transporter, rabbit small intestinal brush border membrane vesicles were submitted to photoaffinity labeling using photoreactive derivatives of 2-azetidinone cholesterol absorption inhibitors. An integral membrane protein of M(r) 145.3+/-7.5 kDa was specifically labeled in brush border membrane vesicles from rabbit jejunum and ileum. Its labeling was concentration-dependently inhibited by the presence of cholesterol absorption inhibitors whereas bile acids, D-glucose, fatty acids or cephalexin had no effect. The inhibitory potency of 2-azetidinones to inhibit photolabeling of the 145 kDa protein correlated with their in vivo activity to inhibit intestinal cholesterol absorption. These results suggest that an integral membrane protein of M(r) 145 kDa is (a component of) the cholesterol absorption system in the brush border membrane of small intestinal enterocytes.

摘要

为鉴定肠道胆固醇转运蛋白的组成成分,使用2-氮杂环丁酮胆固醇吸收抑制剂的光反应衍生物对兔小肠刷状缘膜囊泡进行光亲和标记。在兔空肠和回肠的刷状缘膜囊泡中,一种相对分子质量为145.3±7.5 kDa的整合膜蛋白被特异性标记。胆固醇吸收抑制剂的存在可浓度依赖性地抑制其标记,而胆汁酸、D-葡萄糖、脂肪酸或头孢氨苄则无影响。2-氮杂环丁酮抑制145 kDa蛋白光标记的抑制效力与其体内抑制肠道胆固醇吸收的活性相关。这些结果表明,相对分子质量为145 kDa的整合膜蛋白是小肠肠上皮细胞刷状缘膜中胆固醇吸收系统的(一个组成成分)。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验